To assess safety and tolerability after treatment with LEO 134310 cutaneous solution.
Age range
18 Years – 64 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Overall number of treatment-emergent adverse events.
Timeframe: Up to Day 19
Number of treatment-emergent application site reactions, by treatment.
Timeframe: Up to Day 19
Change from baseline to Day 4, Day 8 and Day 12 in haematology parameters
Timeframe: Up to Day 12
Change from baseline to Day 4, Day 8 and Day 12 in clinical chemistry parameters
Timeframe: Up to Day 12
Change from baseline to Day 4, Day 8 and Day 12 in urinalysis parameters
Timeframe: Up to Day 12
Number of subjects with abnormal clinical significant ECG evaluation
Timeframe: Up to Day 12
Number of subjects with abnormal clinically significant findings of physical examination at Day 12.
Timeframe: Up to Day 12
Change from baseline to Day 4, Day 8, Day 12 in systolic and diastolic blood pressure.
Timeframe: Up to Day 12
Change from baseline to Day 4, Day 8 and Day 12 in pulse.
Timeframe: Up to Day 12
Change from baseline to Day 4, Day 8 and Day 12 in oral body temperature.
Timeframe: Up to Day 12